Literature DB >> 2464906

Heparan sulfate degradation in tumor cell invasion and angiogenesis.

I Vlodavsky1, A Eldor, M Bar-Ner, R Fridman, I R Cohen, M Klagsbrun.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2464906     DOI： 10.1007/978-1-4899-5037-6_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  8 in total

Review 1.  Inhibition of fibroblast growth factors.

Authors:  A Wellstein; F Czubayko
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  Antiangiogenic effect of sulphated and nonsulphated glycosaminoglycans and polysaccharides in the chick embryo chorioallantoic membrane.

Authors:  R Hahnenberger; A M Jakobson
Journal:  Glycoconj J       Date:  1991-08       Impact factor: 2.916

3.  Differential effects of Heparitinase I and Heparitinase III on endothelial tube formation in vitro.

Authors:  Karthik Raman; Balagurunathan Kuberan
Journal:  Biochem Biophys Res Commun       Date:  2010-06-17       Impact factor: 3.575

Review 4.  How do normal and leukemic white blood cells egress from the bone marrow? Morphological facts and biochemical riddles.

Authors:  P E Petrides; K H Dittmann
Journal:  Blut       Date:  1990-07

5.  Tumor-derived syndecan-1 mediates distal cross-talk with bone that enhances osteoclastogenesis.

Authors:  Thomas Kelly; Larry J Suva; Kristy M Nicks; Veronica MacLeod; Ralph D Sanderson
Journal:  J Bone Miner Res       Date:  2010-06       Impact factor: 6.741

6.  Expression of a Secreted Fibroblast Growth Factor Binding Protein-1 (FGFBP1) in Angioproliferative Kaposi Sarcoma.

Authors:  Patricio E Ray; Ali Al-Attar; Xue-Hui Liu; Jharna R Das; Elena Tassi; Anton Wellstein
Journal:  J AIDS Clin Res       Date:  2014-06

7.  Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition.

Authors:  Irina Kareva; Abdo Abou-Slaybi; Oliver Dodd; Olga Dashevsky; Giannoula Lakka Klement
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

Review 8.  A Combination of Immune Checkpoint Inhibition with Metronomic Chemotherapy as a Way of Targeting Therapy-Resistant Cancer Cells.

Authors:  Irina Kareva
Journal:  Int J Mol Sci       Date:  2017-10-13       Impact factor: 5.923
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.